Literature DB >> 11788124

Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease.

G Franceschini1.   

Abstract

Plasma high-density lipoprotein cholesterol (HDL-C) is inversely related to coronary artery disease incidence in both women and men, with a proportionately increasing effect of HDL-C throughout the average (or slightly above average)-to-low concentration range. A substantial body of evidence from major epidemiologic studies has established that this coronary artery disease risk associated with HDL-C is entirely independent of plasma low-density lipoprotein cholesterol, other lipid parameters (triglycerides, total cholesterol), and other nonlipid risk factors. The coronary artery disease relative risk for patients with low levels of HDL-C in conjunction with low total cholesterol is also markedly higher than in patients with a profile of high levels of these 2 lipid parameters. Similarly, the risk associated with a low HDL-C level is of particular significance in patients with established coronary artery disease or with type 2 diabetes, and it is a more pertinent factor to consider when managing dyslipidemia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11788124     DOI: 10.1016/s0002-9149(01)02146-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  22 in total

1.  Using advanced intercross lines for high-resolution mapping of HDL cholesterol quantitative trait loci.

Authors:  Xiaosong Wang; Isabelle Le Roy; Edwige Nicodeme; Renhua Li; Richard Wagner; Christina Petros; Gary A Churchill; Stephen Harris; Ariel Darvasi; Jorge Kirilovsky; Pierre L Roubertoux; Beverly Paigen
Journal:  Genome Res       Date:  2003-06-12       Impact factor: 9.043

Review 2.  Raising high-density lipoprotein cholesterol: innovative strategies against an old adversary.

Authors:  Dhruv Kazi; John A Farmer
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

Review 3.  The role of HDL in plaque stabilization and regression: basic mechanisms and clinical implications.

Authors:  Jonathan E Feig; Jessica L Feig; George D Dangas
Journal:  Coron Artery Dis       Date:  2016-11       Impact factor: 1.439

4.  HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells.

Authors:  Jonathan E Feig; James X Rong; Raanan Shamir; Marie Sanson; Yuliya Vengrenyuk; Jianhua Liu; Katey Rayner; Kathryn Moore; Michael Garabedian; Edward A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

Review 5.  Stabilization of high-risk plaques.

Authors:  Kohei Takata; Satoshi Imaizumi; Bo Zhang; Shin-Ichiro Miura; Keijiro Saku
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

Review 6.  Novel biological functions of high-density lipoprotein cholesterol.

Authors:  Chieko Mineo; Philip W Shaul
Journal:  Circ Res       Date:  2012-09-28       Impact factor: 17.367

Review 7.  High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies.

Authors:  Jonathan E Feig; Bernd Hewing; Jonathan D Smith; Stanley L Hazen; Edward A Fisher
Journal:  Circ Res       Date:  2014-01-03       Impact factor: 17.367

8.  A genome-wide scan for quantitative trait loci affecting serum glucose and lipids in a White Duroc x Erhualian intercross F(2) population.

Authors:  Rongrong Chen; Jun Ren; Wanbo Li; Xiang Huang; Xueming Yan; Bin Yang; Yinggong Zhao; Yuanmei Guo; Huirong Mao; Lusheng Huang
Journal:  Mamm Genome       Date:  2009-06-04       Impact factor: 2.957

9.  Add-on memantine to valproate treatment increased HDL-C in bipolar II disorder.

Authors:  Sheng-Yu Lee; Shiou-Lan Chen; Yun-Hsuan Chang; Po See Chen; San-Yuan Huang; Nian-Sheng Tzeng; Yu-Shan Wang; Liang-Jen Wang; I Hui Lee; Tzung Lieh Yeh; Yen Kuang Yang; Ru-Band Lu; Jau-Shyong Hong
Journal:  J Psychiatr Res       Date:  2013-07-18       Impact factor: 4.791

10.  Multiple splice defects in ABCA1 cause low HDL-C in a family with hypoalphalipoproteinemia and premature coronary disease.

Authors:  Jeffrey Rhyne; Myrna M Mantaring; David F Gardner; Michael Miller
Journal:  BMC Med Genet       Date:  2009-01-08       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.